MR-Adaptive Radiation Therapy for Anal Cancer With EScalated-Treatment in a Risk-Optimized Approach
Condition: Anal Squamous Cell Carcinoma Interventions: Radiation: Radiotherapy - Low risk group; Radiation: Radiotherapy - Standard risk group; Radiation: Radiotherapy - Intermediate risk group; Radiation: Radiotherapy - High risk group Sponsor: University Health Network, Toronto Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials